5-OXO-L-NORLEUCINE L-peptide linking ATOMP C6 H11 N O3 0 1999-07-08 2011-06-04 N REL 145.156 X ONL N Corina N 1ECG EBI N N 0 1 N N N 76.787 15.603 32.096 1.150 1.861 -0.131 N ONL 1 CA C 0 1 N N S 75.365 15.943 32.397 1.090 0.512 0.448 CA ONL 2 C C 0 1 N N N 74.800 16.645 31.197 2.319 -0.262 0.047 C ONL 3 O O 0 1 N N N 73.570 16.730 31.152 2.967 0.089 -0.910 O ONL 4 OXT O 0 1 N Y N 75.596 17.132 30.352 2.692 -1.341 0.752 OXT ONL 5 CB C 0 1 N N N 75.252 16.894 33.582 -0.158 -0.208 -0.066 CB ONL 6 CG C 0 1 N N N 76.241 18.024 33.529 -1.409 0.508 0.447 CG ONL 7 CD C 0 1 N N N 76.409 18.678 34.881 -2.638 -0.201 -0.060 CD ONL 8 OD O 0 1 N N N 76.502 17.998 35.909 -2.525 -1.179 -0.759 OD ONL 9 CE C 0 1 N N N 76.410 20.204 34.938 -4.008 0.310 0.306 CE ONL 10 HN1 H 0 1 N N N 76.910 15.527 31.106 1.930 2.381 0.243 HN1 ONL 11 HN2 H 0 1 N Y N 77.384 16.322 32.452 1.192 1.821 -1.138 HN2 ONL 12 HA H 0 1 N N N 74.826 15.015 32.637 1.045 0.585 1.535 HA ONL 13 HXT H 0 1 N Y N 75.104 17.577 29.672 3.487 -1.805 0.456 HXT ONL 14 HB1 H 0 1 N N N 74.239 17.322 33.585 -0.157 -0.203 -1.156 HB1 ONL 15 HB2 H 0 1 N N N 75.464 16.313 34.492 -0.157 -1.238 0.292 HB2 ONL 16 HG1 H 0 1 N N N 77.214 17.628 33.204 -1.410 0.503 1.536 HG1 ONL 17 HG2 H 0 1 N N N 75.865 18.780 32.824 -1.410 1.538 0.088 HG2 ONL 18 HE1 H 0 1 N N N 76.410 20.532 35.988 -4.338 1.030 -0.442 HE1 ONL 19 HE2 H 0 1 N N N 77.308 20.589 34.433 -4.709 -0.524 0.342 HE2 ONL 20 HE3 H 0 1 N N N 75.512 20.590 34.434 -3.967 0.792 1.282 HE3 ONL 21 sing N N 1 sing N N 2 sing N N 3 sing N N 4 sing N N 5 sing N N 6 doub N N 7 sing N N 8 sing N N 9 sing N N 10 sing N N 11 sing N N 12 sing N N 13 sing N N 14 sing N N 15 doub N N 16 sing N N 17 sing N N 18 sing N N 19 sing N N 20 O=C(CCC(N)C(=O)O)C CC(=O)CC[C@H](N)C(O)=O CC(=O)CC[CH](N)C(O)=O CC(=O)CC[C@@H](C(=O)O)N CC(=O)CCC(C(=O)O)N InChI=1S/C6H11NO3/c1-4(8)2-3-5(7)6(9)10/h5H,2-3,7H2,1H3,(H,9,10)/t5-/m0/s1 KSIJECNNZVKMJG-YFKPBYRVSA-N 5-oxo-L-norleucine (2S)-2-amino-5-oxo-hexanoic acid EBI RCSB